RxDoctor Payments Data

Matthew Jung, MD

Otolaryngology · Olympia, WANPI 1376839944

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,899 of the $2,616 with a category attached, or 72.6%. 22 manufacturers reported payments, led by Medical Device Business Services, Inc. at 27.4% of the total. Reporting peaked in 2019 at $1,127 and has fallen 58.6% since, to $466 in 2025.

$2,616in general payments, 2019–2025

Across 58 payments — averaging $45.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$717
  • Aerin Medical Inc.$372
  • Medtronic$351
  • Integra Lifesciences Corporation$205
  • GSK$172
  • Alk-abello, Inc$119
  • plus $680 from 16 others

What the payments were for

  • Travel & lodging$71727%
  • Food & beverage$1,89973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,616 in reported general payments places this provider in the 85th percentile of 254 otolaryngology providers in Washington.

See all otolaryngology providers in Washington

Medicare billing

Part B allowed, 2024
$188,829
Medicare patients
606
Services billed
2,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl455$12,666
Ipratropium Bromide204$6,059
Fluticasone Propionate303$3,870
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,406
Ofloxacin40$1,442
Montelukast Sodium104$900
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$764
Tobramycin-DexamethasoneTobramycin/Dexamethasone11$688
Mupirocin65$545
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$514
Cefdinir22$513
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$140
Prednisone16$115
Omeprazole12$92
Oxycodone Hcl13$25

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →